4 terminated. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 3 | 1 | Terminated 1 |
Follow Ticagrelor: new trials by email Literature Review of Ticagrelor trials Research Report on Ticagrelor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy Dual Antiplatelet (DAPT) Therapy, The Synergy® stent - Coronary Artery Disease, Atherosclerosis | Phase 2 | Terminated | HonorHealth Research Institute | 50 | 2018-11-19 | 2024-12-27 |
| Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR Ticagrelor, Comparator - Peripheral Artery Disease (PAD) | Phase 2 | Terminated | AstraZeneca | 40 | 2014-10-20 | 2017-07-19 |
| Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia Ticagrelor, Clopidogrel - Peripheral Arterial Disease | Phase 2 / Phase 3 | Terminated | The Cleveland Clinic | 46 | 2014-10-01 | 2021-07-07 |
| Ticagrelor in Severe Community Acquired Pneumonia Ticagrelor, Placebo - Community Acquired Pneumonia, Severe | Phase 2 | Terminated | Gordon Bernard | 25 | 2014-08-01 | 2017-12-11 |
Cardiovascular Diseases (2) · Peripheral Arterial Disease (2) · Peripheral Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Community-Acquired Pneumonia (1) · Coronary Artery Disease (1) · Heart Diseases (1) · Ischemia (1) · Myocardial Infarction (1) · Pneumonia (1) · Vascular Diseases (1)
AstraZeneca (1) · Gordon Bernard (1) · HonorHealth Research Institute (1) · The Cleveland Clinic (1)
United States (4)
David Rizik, MD (1) · Gordon R Bernard, MD (1) · Jon D Truwit, MD (1) · Joseph Campbell, MD (1) · William Hiatt, MD (1)